Search:
Scroll to top
Tag: digital therapeutics
10/31/2022

Digital Health Summit Brings Together Leaders In Digital Therapeutics

Article Excerpt: Players from across the healthcare industry — including providers, payers, researchers, regulators and investors — will converge on Hanover Wednesday, November 2 for a digital health summit entitled “Clinically Validated Digital Therapeutics: Paths to Deployment.” The event, hosted by the Center for Technology and Behavioral Health (CTBH) and The Magnuson Center for Entrepreneurship at Dartmouth College, will cover the current state of digital therapeutics, and explore the paths to global deployment of this innovative type of healthcare. “We have a community, here at Dartmouth, that’s very well known for expertise in digital therapeutics,” says Lisa A. Marsch, Ph.D., Director of CTBH. CTBH is a nationally recognized Center of Excellence, funded by the National Institute on Drug Abuse.

Full Article: https://tinyurl.com/mryf2uvj

Article Source: The Magnuson Center Blog

Posted in: Dissemination & Implementation // Tagged: ; ; ; ;
10/23/2022

Can VR Act as A Digital Therapeutic?

Article Excerpt: Our digital, two-dimensional lives leave little room for focus. Our eyes dart from screen to screen over the course of the day as notifications and messages draw our attention away from tasks, from relaxation, from the faces of our loved ones. Through all of its flatness, our digital lives are dominated by distraction—so much so that we can sometimes forget to breathe. Finding lasting inner peace from within this flattened world can be a neurological nightmare. Mindfulness and meditation apps, digital health’s answer in the last decade, use many of the same engagement methods that have propelled other consumer applications like games and fitness apps to success. Strategies like achievements and social connectivity have kept many users coming back to engage in evidence-based, clinically effective therapies. But even the most effective and engaging mindfulness apps can’t transcend the noise and distraction of our everyday lives.

Full Article: https://tinyurl.com/mryfpr8m

Article Source: Fast Company

Posted in: Emerging Technologies // Tagged: ; ; ; ; ;
09/14/2022

Physician Adoption of Digital Health Tools Is Accelerating, AMA Research Shows

Article Excerpt: The American Medical Association’s digital health research released today shows increased rates of digital health adoption among physicians over the last six years and provides insights into their expectations. “The AMA survey illustrates the importance physicians place on validated digital health tools that improve health while streamlining the technological and administrative burdens faced each day in medicine,” said AMA President Dr. Jack Resneck Jr. in a statement. “These technologies also must be designed and deployed in ways that advance health equity,” he added.

Full Article: https://tinyurl.com/ykvhp5jz

Article Source: Health IT News

Posted in: Methodologies & Analytics // Tagged: ; ; ; ; ; ;
08/02/2022

How Much Are Patients Actually Using Mental Health Apps? Research on Engagement Is Elusive

Article Excerpt: As companies selling health care apps struggle to prove to a skeptical system that they really deliver results, we’re about to start hearing a lot more about “engagement.” A new paper scrutinizing six clinical trials supporting four mental health apps cleared by the Food and Drug Administration argues there’s an urgent need to close the “gap between intention and real-world efficacy for digital therapeutics” — specifically, the dearth of data on how much people actually use digital treatments.

Full Article: https://tinyurl.com/nxu5kryh

Article Source: STAT News

Posted in: Methodologies & Analytics // Tagged: ; ; ; ; ;
08/01/2022

Digital Therapeutic Improves Symptoms of Insomnia, Anxiety, Depression for 6 Months

Article Excerpt: Data from a real-world study revealed that treatment with prescription digital therapeutic Somryst achieved reductions in symptoms of insomnia, anxiety and depression, per a late-breaking poster at the SLEEP meeting.Somryst is the only FDA-authorized prescription digital therapeutic for the treatment of chronic insomnia, manufacturer Pear Therapeutics stated in a related press release. “Chronic insomnia is often associated with depression and anxiety so it’s important to evaluate the impact of insomnia treatment on such psychiatric comorbidities,” Yuri Maricich, MD, MBA, Pear Therapeutics chief medical officer and head of development, said in the release.

Full Article: https://tinyurl.com/3drnwpnx

Article Source: Healio

Posted in: Emerging Technologies // Tagged: ; ; ; ; ; ; ;
07/12/2022

Digital Therapeutic for Substance Use Disorder Drives Down Care Utilization, Cost

Article Excerpt: Digital therapeutics firm Pear Therapeutics has released new data showing its prescription substance use disorder (SUD) therapy reduces hospitalizations and lowers healthcare costs for patients. The data will be published in the journal Advances in Therapy, but the findings are currently available online as a pre-print. The treatment is called reSET. The app is built around cognitive behavioral therapy (CBT) utilizing the community reinforcement approach (CRA), the company said. It includes a 12-week course of therapy, in which patients are incentivized for completing lessons and abstaining from drug use. The app also includes fluency training designed to reinforce the lesson content. Previous studies have shown the therapy can be effective at improving rates of abstinence and treatment retention when coupled with usual treatments. In the new report, investigators wanted to know how such improvements might translate into changes in healthcare resource utilization and costs.

Full Article: https://tinyurl.com/ybezxs3e

Article Source: Managed Healthcare Executive

Posted in: Emerging Technologies // Tagged: ; ; ; ; ; ; ;
06/23/2022

Digital Therapeutics Are Modern Day Digital Engineers

Article Excerpt: Suffering from chronic pain or IBS ? or want to reverse newly diagnosed diabetes? Software engineers have exciting solutions that are backed by the USFDA. Digital therapeutics (DTx ) are the newer options for patients. They are high-quality mobile-friendly software application-driven interventions to prevent, manage or treat diseases. Backed by AI, they provide personalized solutions. Scientifically established and evidence-based, they can be as effective as pharmaceutical pills.

Full Article: https://tinyurl.com/yvp2k274

Article Source: BW Healthcare World

Posted in: Emerging Technologies // Tagged: ; ; ; ; ; ;
05/12/2022

Digital-Therapeutics Offer a New Model for Medicine, but Face Obstacles

Article Excerpt: Startups have raised billions of dollars in venture capital to develop software-based digital therapeutics for a range of diseases. Now, many are wrestling with the challenge of bringing these treatments to patients. Several are experimenting with new business strategies to clear hurdles to commercial success.

Full Article: https://tinyurl.com/yhezfdtv

Article Source: The Wall Street Journal

Posted in: Emerging Technologies // Tagged: ; ; ; ;
04/26/2022

Biden’s National Drug Control Strategy Prioritizes Digital Therapeutics Reimbursement for Substance Use

Article Excerpt: The Biden Administration is encouraging new digital therapeutics reimbursement strategies in both the public and private sector as part of its National Drug Control Strategy report. In the plan the White House pitches digital therapeutics, evidence-based treatments delivered through software interventions to treat or manage a condition, as a potential tool to help expand access to substance use disorder (SUD) treatments. The reimbursement plans, which was first spotted by Exits and Outcomes, was part of a larger plan to tackle substance use disorders.

Full Article: https://tinyurl.com/mr82ered

Article Source: Behavioral Health Business

Posted in: Emerging Technologies, Regulation & Policy // Tagged: ; ; ; ; ;